Literature DB >> 2342798

Presence and rapid decline of early morning intraocular pressure peaks in glaucoma patients.

R C Zeimer1, J T Wilensky, D K Gieser.   

Abstract

A group of nine glaucoma patients in whom home tonometry, with the self-tonometer, had previously demonstrated elevated intraocular pressure (IOP) peaks upon waking were asked to measure their IOPs when they awoke in the morning, 30 minutes later, and 1 hour later. This was repeated for 4 days and medication was taken only after the third measurement. Eight of the nine patients demonstrated a reproducible decrease in IOP ranging from 2 to 18 mmHg within 30 minutes. There are indications that the momentary IOP elevation is associated with wakening. This phenomenon raises interesting questions regarding IOP variations. It indicates that in certain cases significant IOP peaks disappear before the patient can reach the clinic and may have an effect on loss of vision.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342798     DOI: 10.1016/s0161-6420(90)32543-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Diurnal versus office-hour intraocular pressure fluctuation in primary adult onset glaucoma.

Authors:  Tarun Arora; Shveta Jindal Bali; Vishal Arora; Meenakshi Wadhwani; Anita Panda; Tanuj Dada
Journal:  J Optom       Date:  2014-06-16

2.  Importance of early morning intraocular pressure recording for measurement of diurnal variation of intraocular pressure.

Authors:  P P Syam; I Mavrikakis; C Liu
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 3.  Diurnal variations in intraocular pressure.

Authors:  J T Wilensky
Journal:  Trans Am Ophthalmol Soc       Date:  1991

4.  A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.

Authors:  S M Whitcup; L B Cantor; A M VanDenburgh; K Chen
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

5.  Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes.

Authors:  Guorong Li; Dibyendu Mukherjee; Iris Navarro; Nicole E Ashpole; Joseph M Sherwood; Jinlong Chang; Darryl R Overby; Fan Yuan; Pedro Gonzalez; Casey C Kopczynski; Sina Farsiu; W Daniel Stamer
Journal:  Eur J Pharmacol       Date:  2016-04-13       Impact factor: 4.432

6.  Diurnal intraocular pressure variations: an analysis of 690 diurnal curves.

Authors:  R David; L Zangwill; D Briscoe; M Dagan; R Yagev; Y Yassur
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

7.  Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment study.

Authors:  Stuart K Gardiner; Shaban Demirel; Mae O Gordon; Michael A Kass
Journal:  Ophthalmology       Date:  2013-01-26       Impact factor: 12.079

8.  Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans.

Authors:  C A McCannel; S R Heinrich; R F Brubaker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

9.  Are large optic nerve heads susceptible to glaucomatous damage at normal intraocular pressure? A three-dimensional study by laser scanning tomography.

Authors:  R O Burk; K Rohrschneider; H Noack; H E Völcker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

10.  EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study.

Authors:  Michael S Berlin; Cheryl Rowe-Rendleman; Ike Ahmed; Douglas T Ross; Akifumi Fujii; Takafumi Ouchi; Christine Quach; Andrew Wood; Caroline L Ward
Journal:  Br J Ophthalmol       Date:  2015-10-09       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.